Skip to NavigationSkip to content

Business Services

Top Ten most popular articles on this week

It's Friday, so it's time to bring you another run-down of the top ten most popular articles with's readers this week.

Despite a drought of mergers and acquisitions throughout 2017, rumours are already circulating on what deals may occur this year, and among them, Celgene is expected to attempt to acquire Juno Therapeutics and the valuable CAR T therapy it is developing for $7 billion.

Riding the wave: The FDA and real world evidence

Published on 18/01/18 at 10:23am

Following on from this week's earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER's Office of Medical Policy at the FDA, tells Pharmafocus how the US regulator has and continues to embrace the technology.

GSK Consumer Healthcare announces new Asia Pacific Regional Head

Published on: 16/01/18

GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing operations in 23 countries. He will also take on membership of GSK’s consumer healthcare strategic leadership team and Singapore country board.

He replaces Zubair Ahmed, who assumes the role of Non-Executive Chairman of India Board.

Hikma bring in new CSO

Published on: 16/01/18

Hikma Pharmaceuticals has announced that Surendera Tyagi is being brought in to join the company as Group Chief Scientific Officer and Global Head of R&D. The company revealed that Tyagi’s principal role will be to inject some life into the group’s non-injectables business during his first year with Hikma.

Seizing opportunities in the next steps for real world evidence

Published on 15/01/18 at 11:12am

Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may hold for changing the way we track a particular medicine's efficacy. Matt Fellows has compiled some of the latest thought leadership on the challenges that lie ahead for wider adoption of the technology.

Top Ten most popular articles on this week

The Xmas break is now a distant memory as we move further into January, and with another Friday comes another rundown of the top ten most popular news stories with readers this week.

Among the top stories this week was the news that Shire is to split its business into two distinct units, Nestle could be the frontrunner in the competition to acquire Merck KGaA's consumer health unit, and a remarkable once-weekly, slow-release HIV pill has been developed.

Novartis prises Pfizer's Oncology Head away

Published on: 11/01/18

Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he would be leaving the position of CEO of Novartis Oncology due to personal reasons last month. The target that Novartis eventually settled on was Elizabeth Barrett, current Global President & General Manager of Oncology at Pfizer.

Dr Aidan Murphy becomes Ipsen's new Executive VP, Technical Operations

Published on: 10/01/18

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at the end of 2017. In addition to his new position, Dr Murphy will also serve on the French biopharmaceutical company’s executive leadership team.

Ex-Genentech exec named as new Juno Therapeutics CIO

Published on: 08/01/18

Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she will report to President and CEO Hans Bishop.

The PROs and cons of pushing patient centricity

Published on 08/01/18 at 11:06am

As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how this relationship can be mutually beneficial.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches